IDYA
Ideaya Biosciences Inc
36.10$
-0.6%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | 100.0% | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | – | – | – | – | – | – | 3.2% | 3.4% | 159.6% | 171.1% | 172.7% | 14.3% | 4.1% | 20.6% | 3.1% | 13.9% | 12.2% | 28.2% | 12.3% | 26.1% | – | – | – | 9.2% | – | – | 39.9% | 796.2% | 1,459.2% | – | – | |
| – | – | – | – | – | – | – | – | – | – | 96.8% | 96.6% | -59.6% | -71.1% | -72.7% | 85.7% | 95.9% | 79.4% | 96.9% | 86.1% | 87.8% | 71.8% | 87.7% | 73.9% | – | – | – | 90.8% | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | – | – | – | – | – | – | 111.8% | 114.0% | 159.6% | 171.1% | 172.7% | 543.7% | 173.0% | 389.6% | 75.3% | 614.5% | 353.5% | 823.3% | 419.3% | 988.3% | – | – | – | 2,002.6% | – | – | 39.9% | 796.2% | 1,459.2% | 1,227.2% | 159.7% | |
| – | – | – | – | – | – | – | – | – | – | 43.9% | 35.9% | 66.5% | 55.1% | 57.8% | 176.3% | 52.1% | 94.9% | 22.4% | 143.0% | 79.9% | 199.6% | 97.8% | 180.2% | – | – | – | 156.5% | – | – | 7.9% | 173.3% | 295.4% | 253.6% | 32.9% | |
| – | – | – | – | – | – | – | – | – | – | 152.4% | 146.5% | 66.5% | 55.1% | 57.8% | 705.6% | 221.1% | 464.0% | 94.7% | 743.6% | 421.3% | 994.8% | 504.8% | 1,142.3% | – | – | – | 2,149.9% | – | – | 47.8% | 969.5% | 1,754.6% | 1,480.7% | 192.7% | |
| – | – | – | – | – | – | – | – | – | – | -55.7% | -49.9% | -126.1% | -126.2% | -130.5% | -619.9% | -125.2% | -384.5% | 2.2% | -657.5% | -333.5% | -922.9% | -417.1% | -1,068.5% | – | – | – | -2,059.1% | – | – | 52.2% | -869.5% | -1,654.6% | -1,380.7% | -92.7% | |
| – | – | – | – | – | – | – | – | – | – | 0.8% | 8.0% | 1.6% | 1.2% | 3.9% | 679.2% | 1.8% | 7.6% | 3.2% | 55.7% | 45.7% | – | – | 639.0% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -54.9% | -48.6% | -124.5% | -125.0% | -129.0% | -614.6% | -123.4% | -377.0% | 5.4% | -601.7% | -300.0% | -788.0% | -341.4% | -865.5% | – | – | – | -1,861.6% | – | – | 57.4% | -765.7% | -1,502.1% | -1,269.6% | -74.8% | |
| – | – | – | – | – | – | – | – | – | – | -3.9% | 45.1% | – | 0.5% | -222.5% | -679.2% | 16.6% | -7.6% | -3.2% | -55.7% | -45.7% | -28.2% | -12.8% | 143.3% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -54.9% | -48.6% | -124.5% | -125.0% | -129.0% | -614.6% | -123.4% | -377.0% | 5.4% | -601.7% | -300.0% | -788.0% | -341.4% | -865.5% | – | – | – | -1,861.6% | – | – | 57.4% | -765.7% | -1,502.1% | -1,269.6% | -74.8% | |
| – | – | – | – | – | – | – | – | – | – | -51.6% | -45.2% | -119.2% | -120.5% | -123.5% | -600.3% | -119.3% | -356.4% | 8.6% | -587.8% | -287.8% | -759.8% | -329.1% | -839.4% | – | – | – | -1,852.4% | – | – | 57.7% | -759.0% | -1,491.6% | -1,368.1% | -77.6% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.